← FDA Drug Approvals (Drugs@FDA)

BIMATOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2020-01-21

Drug application

FDA Application #

ANDA210515

Application type

Abbreviated New Drug Application (Generic)

Brand name

BIMATOPROST

Generic name

BIMATOPROST

Active ingredients

BIMATOPROST

Dosage form

SOLUTION/DROPS

Route

TOPICAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Limited

First approval

2020-01-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown